Page last updated: 2024-09-02

tryptoquivaline and Parkinson Disease

tryptoquivaline has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Hou, J; Liu, G; Liu, Q; Sun, H; Zhang, D; Zhang, J	1

Other Studies

1 other study(ies) available for tryptoquivaline and Parkinson Disease

Article	Year
P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models. PloS one, 2014, Volume: 9, Issue:7 Topics: Adenosine Triphosphatases; Animals; Antiparkinson Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzeneacetamides; Biological Transport; Blood-Brain Barrier; Dibenzocycloheptenes; Disease Models, Animal; Endothelial Cells; Indoles; Male; Microvessels; Parkinson Disease; Permeability; Phenols; Quinolines; Rats; Rats, Wistar	2014

Article

Year

P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.

PloS one, 2014, Volume: 9, Issue:7

Topics: Adenosine Triphosphatases; Animals; Antiparkinson Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzeneacetamides; Biological Transport; Blood-Brain Barrier; Dibenzocycloheptenes; Disease Models, Animal; Endothelial Cells; Indoles; Male; Microvessels; Parkinson Disease; Permeability; Phenols; Quinolines; Rats; Rats, Wistar

2014